C

Capricor Therapeutics

1 follower

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Employees

11-50

Links

Org chart

Linda Marbán's profile picture
Linda Marbán
Chief Executive Officer
Profile photo

Linda Marbán

Collapse
Aj Bergmann's profile picture
Aj Bergmann
Chief Financial Officer
Kristi A. H. Elliott's profile picture
Kristi A. H. Elliott
Chief Science Officer
Mark Awadalla's profile picture
Mark Awadalla
Chief Development Officer (cdo)
Yushi Feng's profile picture
Yushi Feng
VP of Regulatory Affairs
Jonathan Tayco's profile picture
Jonathan Tayco
Vice President Of Program Management, Operations And Quality
Joe Z.'s profile picture
Joe Z.
Senior IP Counsel

Offices

  1. Something went wrong loading the org chart, please refresh the page.